scholarly journals Management of Severe Gastrointestinal Tuberculosis with Injectable Antituberculous Drugs

2015 ◽  
Vol 43 (3) ◽  
pp. 191-194 ◽  
Author(s):  
Luciano Z. Goldani ◽  
Camila O. Spessatto ◽  
Daltro L. Nunes ◽  
Juliana G. Oliveira ◽  
Eliziane Takamatu ◽  
...  
1950 ◽  
Vol 14 (1) ◽  
pp. 109-117 ◽  
Author(s):  
W.R. Johnson ◽  
R.E. Moyer ◽  
W.S. Schwartz

CHEST Journal ◽  
2001 ◽  
Vol 120 (6) ◽  
pp. 2112 ◽  
Author(s):  
Ken-ichiro Inoue ◽  
Yutaka Kawahito ◽  
Hajime Sano ◽  
Toshikazu Yoshikawa

1997 ◽  
Vol 3 (1) ◽  
pp. 46-51 ◽  
Author(s):  
Eleni Palazidou

The development of the first effective antidepressants in the late 1950s marked a turning point in the treatment of depressive illness. In 1957 the monoamine oxidase inhibitor (MAOI) iproniazid was discovered by chance, while searching for new antituberculous drugs. One year later the tricyclic antidepressant (TCA) imipramine was introduced, having been developed originally as an antipsychotic. A number of other drugs were subsequently added to these two groups of antidepressants, which dominated the field for the next three decades.


JGH Open ◽  
2018 ◽  
Vol 3 (1) ◽  
pp. 32-37 ◽  
Author(s):  
Sarthak Malik ◽  
Kusum Sharma ◽  
Kim Vaiphei ◽  
Narendra Dhaka ◽  
Neha Berry ◽  
...  

2000 ◽  
Vol 34 (1) ◽  
pp. 11-18 ◽  
Author(s):  
L. A. Kayukova ◽  
K. D. Praliev

Author(s):  
Rajoo Chhina ◽  
Deepinder Chhina ◽  
Prabha Desikan

2019 ◽  
Vol 7 (12) ◽  
pp. 2375-2378
Author(s):  
Parvin Abedi ◽  
Pezhman Alavinejad ◽  
Seyed Jalal Hashemi ◽  
Fatemeh Ahmadi

Sign in / Sign up

Export Citation Format

Share Document